Book Cover
Home  |   Healthcare   |  Psoriasis Drugs Market

Psoriasis Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Biologic Drugs, Small Molecule Systemic Drugs, Tropical Therapies), By Application (TNF Alpha Inhibitors, PDE4 Inhibitors, Interleukin Inhibitors, Other Mechanisms of Action), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Detailed TOC of Global Psoriasis Drugs Market Trends Analysis Report 2026, Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Psoriasis Drugs Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Psoriasis Drugs Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Psoriasis Drugs Business Mode and Production Process
2.3.1 Psoriasis Drugs Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Psoriasis Drugs Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Psoriasis Drugs
2.4.2 Raw Material Cost of Psoriasis Drugs
2.4.3 Labor Cost of Psoriasis Drugs
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Psoriasis Drugs Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Psoriasis Drugs Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Psoriasis Drugs Price by Manufacturer (2021-2026)
4.4 Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Psoriasis Drugs, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Psoriasis Drugs, Product Offered and Application
4.7 Psoriasis Drugs Market Competitive Situation and Trends
4.7.1 Psoriasis Drugs Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Psoriasis Drugs Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Psoriasis Drugs Market Historical Development by Geographic Region (2021-2026)
5.1 Global Psoriasis Drugs Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Psoriasis Drugs Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Psoriasis Drugs Market Status by Country (2021-2026)
5.3.1 North America Psoriasis Drugs Sales Volume by Country (2021-2026)
5.3.2 North America Psoriasis Drugs Revenue by Country (2021-2026)
5.3.3 United States Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Psoriasis Drugs Market Status by Country (2021-2026)
5.4.1 Europe Psoriasis Drugs Sales Volume by Country (2021-2026)
5.4.2 Europe Psoriasis Drugs Revenue by Country (2021-2026)
5.4.3 Germany Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Psoriasis Drugs Market Status by Country (2021-2026)
5.5.1 Asia Pacific Psoriasis Drugs Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Psoriasis Drugs Revenue by Country (2021-2026)
5.5.3 China Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Psoriasis Drugs Market Status by Country (2021-2026)
5.6.1 Latin America Psoriasis Drugs Sales Volume by Country (2021-2026)
5.6.2 Latin America Psoriasis Drugs Revenue by Country (2021-2026)
5.6.3 Mexico Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Psoriasis Drugs Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Psoriasis Drugs Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Psoriasis Drugs Revenue by Country (2021-2026)
5.7.3 GCC Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Psoriasis Drugs Sales Volume, Revenue and Growth (2021-2026)

6 Global Psoriasis Drugs Market Historical Development by Product Type (2021-2026)
6.1 Psoriasis Drugs Definition by Type
6.2 Global Psoriasis Drugs Historical Sales Volume by Product Type (2021-2026)
6.3 Global Psoriasis Drugs Historical Revenue by Product Type (2021-2026)
6.4 Global Psoriasis Drugs Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of Biologic Drugs (2021-2026)
6.5.2 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of Small Molecule Systemic Drugs (2021-2026)
6.5.3 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of Tropical Therapies (2021-2026)

7 Global Psoriasis Drugs Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Psoriasis Drugs Historical Sales Volume by End User (2021-2026)
7.3 Global Psoriasis Drugs Historical Revenue by End User (2021-2026)
7.4 Global Psoriasis Drugs Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of TNF Alpha Inhibitors (2021-2026)
7.5.2 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of PDE4 Inhibitors (2021-2026)
7.5.3 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of Interleukin Inhibitors (2021-2026)
7.5.4 Global Psoriasis Drugs Historical Sales Volume, Revenue and Growth Rate of Other Mechanisms of Action (2021-2026)

8 Leading Companies Profiles
8.1 Amgen
8.1.1 Amgen Corporation Information
8.1.2 Amgen - Psoriasis Drugs Product Portfolio and Specification
8.1.3 Amgen Performance Analysis (2021-2026)
8.1.4 Amgen Business and Markets Served
8.1.5 Amgen Recent Developments
8.2 Biogen
8.2.1 Biogen Corporation Information
8.2.2 Biogen - Psoriasis Drugs Product Portfolio and Specification
8.2.3 Biogen Performance Analysis (2021-2026)
8.2.4 Biogen Business and Markets Served
8.2.5 Biogen Recent Developments
8.3 UCB
8.3.1 UCB Corporation Information
8.3.2 UCB - Psoriasis Drugs Product Portfolio and Specification
8.3.3 UCB Performance Analysis (2021-2026)
8.3.4 UCB Business and Markets Served
8.3.5 UCB Recent Developments
8.4 AstraZeneca
8.4.1 AstraZeneca Corporation Information
8.4.2 AstraZeneca - Psoriasis Drugs Product Portfolio and Specification
8.4.3 AstraZeneca Performance Analysis (2021-2026)
8.4.4 AstraZeneca Business and Markets Served
8.4.5 AstraZeneca Recent Developments
8.5 Stiefel Laboratories
8.5.1 Stiefel Laboratories Corporation Information
8.5.2 Stiefel Laboratories - Psoriasis Drugs Product Portfolio and Specification
8.5.3 Stiefel Laboratories Performance Analysis (2021-2026)
8.5.4 Stiefel Laboratories Business and Markets Served
8.5.5 Stiefel Laboratories Recent Developments
8.6 AbbVie
8.6.1 AbbVie Corporation Information
8.6.2 AbbVie - Psoriasis Drugs Product Portfolio and Specification
8.6.3 AbbVie Performance Analysis (2021-2026)
8.6.4 AbbVie Business and Markets Served
8.6.5 AbbVie Recent Developments
8.7 Novartis AG
8.7.1 Novartis AG Corporation Information
8.7.2 Novartis AG - Psoriasis Drugs Product Portfolio and Specification
8.7.3 Novartis AG Performance Analysis (2021-2026)
8.7.4 Novartis AG Business and Markets Served
8.7.5 Novartis AG Recent Developments
8.8 Takeda Pharmaceutical
8.8.1 Takeda Pharmaceutical Corporation Information
8.8.2 Takeda Pharmaceutical - Psoriasis Drugs Product Portfolio and Specification
8.8.3 Takeda Pharmaceutical Performance Analysis (2021-2026)
8.8.4 Takeda Pharmaceutical Business and Markets Served
8.8.5 Takeda Pharmaceutical Recent Developments
8.9 Merck
8.9.1 Merck Corporation Information
8.9.2 Merck - Psoriasis Drugs Product Portfolio and Specification
8.9.3 Merck Performance Analysis (2021-2026)
8.9.4 Merck Business and Markets Served
8.9.5 Merck Recent Developments
8.10 Celgene Corporation
8.10.1 Celgene Corporation Corporation Information
8.10.2 Celgene Corporation - Psoriasis Drugs Product Portfolio and Specification
8.10.3 Celgene Corporation Performance Analysis (2021-2026)
8.10.4 Celgene Corporation Business and Markets Served
8.10.5 Celgene Corporation Recent Developments
8.11 Eli Lilly & Company
8.11.1 Eli Lilly & Company Corporation Information
8.11.2 Eli Lilly & Company - Psoriasis Drugs Product Portfolio and Specification
8.11.3 Eli Lilly & Company Performance Analysis (2021-2026)
8.11.4 Eli Lilly & Company Business and Markets Served
8.11.5 Eli Lilly & Company Recent Developments
8.12 Janssen Biotech
8.12.1 Janssen Biotech Corporation Information
8.12.2 Janssen Biotech - Psoriasis Drugs Product Portfolio and Specification
8.12.3 Janssen Biotech Performance Analysis (2021-2026)
8.12.4 Janssen Biotech Business and Markets Served
8.12.5 Janssen Biotech Recent Developments
8.13 Johnson & Johnson
8.13.1 Johnson & Johnson Corporation Information
8.13.2 Johnson & Johnson - Psoriasis Drugs Product Portfolio and Specification
8.13.3 Johnson & Johnson Performance Analysis (2021-2026)
8.13.4 Johnson & Johnson Business and Markets Served
8.13.5 Johnson & Johnson Recent Developments
8.14 Pfizer
8.14.1 Pfizer Corporation Information
8.14.2 Pfizer - Psoriasis Drugs Product Portfolio and Specification
8.14.3 Pfizer Performance Analysis (2021-2026)
8.14.4 Pfizer Business and Markets Served
8.14.5 Pfizer Recent Developments
8.15 Abbvie
8.15.1 Abbvie Corporation Information
8.15.2 Abbvie - Psoriasis Drugs Product Portfolio and Specification
8.15.3 Abbvie Performance Analysis (2021-2026)
8.15.4 Abbvie Business and Markets Served
8.15.5 Abbvie Recent Developments

9 Global Psoriasis Drugs Market Forecast by Product Type and End User (2026-2035)
9.1 Global Psoriasis Drugs Market Forecast by Product Type (2026-2035)
9.1.1 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of Biologic Drugs (2026-2035)
9.1.2 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of Small Molecule Systemic Drugs (2026-2035)
9.1.3 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of Tropical Therapies (2026-2035)
9.2 Global Psoriasis Drugs Market Forecast by End User (2026-2035)
9.2.1 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of TNF Alpha Inhibitors (2026-2035)
9.2.2 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of PDE4 Inhibitors (2026-2035)
9.2.3 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of Interleukin Inhibitors (2026-2035)
9.2.4 Global Psoriasis Drugs Sales Volume, Revenue Forecast and Growth Rate of Other Mechanisms of Action (2026-2035)

10 Global Psoriasis Drugs Market Forecast by Geographic Region (2026-2035)
10.1 Global Psoriasis Drugs Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Psoriasis Drugs Sales Volume, Revenue Forecast and Growth (2026-2035)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer

Captcha refresh

Trusted & Certified

Our Clients